Enhanced MYCN oncogene expression in human neuroblastoma cells results in increased susceptibility to growth inhibition by TNF α
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 170 (3), 1301-1307
- https://doi.org/10.1016/0006-291x(90)90535-u
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Where next with therapy in advanced neuroblastoma?British Journal of Cancer, 1990
- Molecular biology and genetics of human neuroblastomaCancer Genetics and Cytogenetics, 1989
- Two Different Cell Types have Different Major Receptors for Human Tumor Necrosis Factor (TNFα)Published by Elsevier ,1989
- Modulation of tumor necrosis factor-α cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolismBiochemical and Biophysical Research Communications, 1987
- Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolismBiochemical and Biophysical Research Communications, 1987
- Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growthNature, 1987
- Amplification of N-myc in human neuroblastomasTrends in Genetics, 1985
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984
- Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factorJournal of Cellular Physiology, 1983
- Effect of tumour necrosis factor on cultured human melanoma cellsNature, 1975